Literature DB >> 15140392

Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study.

Won Sup Oh1, Ji Yoeun Suh, Jae-Hoon Song, Kwan Soo Ko, Sook-In Jung, Kyong Ran Peck, Nam Yong Lee, Yonghong Yang, Anan Chongthaleong, Cheng-Hsun Chiu, Adeeba Kamarulzaman, Navartnam Parasakthi, M K Lalitha, Jennifer Perera, Ti Teow Yee, Gamini Kumarasinghe, Celia C Carlos.   

Abstract

Seventeen clinical isolates of Streptococcus pneumoniae showing reduced susceptibility to ciprofloxacin (MIC >/= 4 micro g/ml) collected from eight different Asian countries were analyzed by antimicrobial susceptibility, serotyping, pulsed-field gel electrophoresis (PFGE), and DNA sequencing of the quinolone resistance-determining regions (QRDRs) in gyrA, gyrB, parC, and parE. All isolates but one showed more than one amino acid alteration in QRDRs of four responsible genes. Ile460 --> Val in parE was the most common mutation. Data suggest that Lys137 --> Asn in parC may be a primary step in the development of high-level and multiple FQ resistance. An additional mutation of Ser81 --> Phe in gyrA resulted in high-level resistance to ciprofloxacin, levofloxacin, and gatifloxacin, whereas Ser79 --> Phe in parC may exert an important role in the development of moxifloxacin resistance. Two novel amino acid changes in gyrB, Ala390 --> Val and Asn423 --> Thr, were found. Data from PFGE suggest an introduction and local spread of multiple resistant Spain(23F)-1 clone in Hong Kong, but isolates from other Asian countries were not related to this clone.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15140392     DOI: 10.1089/107662904323047781

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  7 in total

1.  Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae.

Authors:  Daniel E Rozen; Lesley McGee; Bruce R Levin; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

2.  High genetic diversity of ciprofloxacin-nonsusceptible isolates of Streptococcus pneumoniae in Poland.

Authors:  Ewa Sadowy; Radosław Izdebski; Anna Skoczyńska; Marek Gniadkowski; Waleria Hryniewicz
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

3.  Bacteremic pneumonia caused by extensively drug-resistant Streptococcus pneumoniae.

Authors:  Cheol-In Kang; Jin Yang Baek; Kyeongman Jeon; So Hyun Kim; Doo Ryeon Chung; Kyong Ran Peck; Nam Yong Lee; Jae-Hoon Song
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

4.  Relative fitness of fluoroquinolone-resistant Streptococcus pneumoniae.

Authors:  Crystal N Johnson; David E Briles; William H Benjamin; Susan K Hollingshead; Ken B Waites
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

5.  Extensively drug-resistant Streptococcus pneumoniae, South Korea, 2011-2012.

Authors:  Sun Young Cho; Jin Yang Baek; Cheol-In Kang; So Hyun Kim; Young Eun Ha; Doo Ryeon Chung; Nam Yong Lee; Kyong Ran Peck; Jae-Hoon Song
Journal:  Emerg Infect Dis       Date:  2014-05       Impact factor: 6.883

6.  Serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates among Croatian adults during a fifteen-year period (2005-2019).

Authors:  Iva Butić; Marija Gužvinec; Marko Jelić; Irena Groš; Sandra Lucić; Mile Bošnjak; Arjana Tambić Andrašević
Journal:  Croat Med J       Date:  2022-04-30       Impact factor: 2.415

7.  Clonal dissemination of extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae isolates in a Korean hospital.

Authors:  Kwan Soo Ko; Joon-Sup Yeom; Mi Young Lee; Kyong Ran Peck; Jae-Hoon Song
Journal:  J Korean Med Sci       Date:  2008-02       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.